Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 1
1999 3
2000 3
2001 3
2002 4
2003 1
2004 6
2005 5
2006 2
2007 5
2008 4
2009 3
2010 5
2011 5
2012 5
2013 1
2014 2
2015 3
2016 4
2017 1
2019 4
2020 1
2021 3
2022 1
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: Randomized Controlled Trial. Clear all
Page 1
Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial.
Ogal M, Johnston SL, Klein P, Schoop R. Ogal M, et al. Eur J Med Res. 2021 Apr 8;26(1):33. doi: 10.1186/s40001-021-00499-6. Eur J Med Res. 2021. PMID: 33832544 Free PMC article. Clinical Trial.
Echinacea prevented 32.5% of RTI episodes resulting in an odds ratio of OR = 0.52 [95% CI 0.30-0.91, p = 0.021]. ...Finally, 76 adverse events occurred with Echinacea and 105 events with vitamin C (p = 0.016), only three events were reported possibly related with …
Echinacea prevented 32.5% of RTI episodes resulting in an odds ratio of OR = 0.52 [95% CI 0.30-0.91, p = 0.021]. ...Finally, 76 adver …
Echinacea can help with Azithromycin in prevention of recurrent tonsillitis in children.
Abdel-Naby Awad OG. Abdel-Naby Awad OG. Am J Otolaryngol. 2020 Jul-Aug;41(4):102344. doi: 10.1016/j.amjoto.2019.102344. Epub 2019 Nov 12. Am J Otolaryngol. 2020. PMID: 32487336 Free PMC article. Clinical Trial.
Group 3 (100 patients) received AZT as in group 2 plus commercially available Echinacea in a dose of 5 ml oral suspension; 3 times daily for 10 consecutive days every month for 6 consecutive months. ...CONCLUSION: The combined use of Echinacea with Azithromycin prod …
Group 3 (100 patients) received AZT as in group 2 plus commercially available Echinacea in a dose of 5 ml oral suspension; 3 times da …
Echinacea angustifolia and Echinacea purpurea Supplementation Combined with Vaginal Hyaluronic Acid to Boost the Remission of Cervical Low-Grade Squamous Intraepithelial Lesions (L-SILs): A Randomized Controlled Trial.
Riemma G, Schettino MT, Munno GM, Fasulo DD, Sandullo L, Amabile E, La Verde M, Torella M. Riemma G, et al. Medicina (Kaunas). 2022 May 9;58(5):646. doi: 10.3390/medicina58050646. Medicina (Kaunas). 2022. PMID: 35630063 Free PMC article. Clinical Trial.
However, evidence regarding the improvement due to Echinacea-based supplements of cervical HPV-related pathologies is still lacking. The aim of this study is to evaluate the efficacy of Echinacea supplementation on the remission of cervical low-grade squamous intrae …
However, evidence regarding the improvement due to Echinacea-based supplements of cervical HPV-related pathologies is still lacking. …
Echinacea for treating the common cold: a randomized trial.
Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Barrett B, et al. Ann Intern Med. 2010 Dec 21;153(12):769-77. doi: 10.7326/0003-4819-153-12-201012210-00003. Ann Intern Med. 2010. PMID: 21173411 Free PMC article. Clinical Trial.
BACKGROUND: Echinacea is widely used to treat the common cold. OBJECTIVE: To assess the potential benefits of echinacea as a treatment of common cold. ...INTERVENTION: Patients were assigned to 1 of 4 parallel groups: no pills, placebo pills (blinded), echinacea …
BACKGROUND: Echinacea is widely used to treat the common cold. OBJECTIVE: To assess the potential benefits of echinacea as a t …
Echinacea purpurea and mucosal immunity.
Hall H, Fahlman MM, Engels HJ. Hall H, et al. Int J Sports Med. 2007 Sep;28(9):792-7. doi: 10.1055/s-2007-964895. Epub 2007 Apr 13. Int J Sports Med. 2007. PMID: 17436202 Clinical Trial.
This investigation examined the effects of Echinacea purpurea on mucosal immunity and the incidence and duration of upper respiratory tract infection (URTI). 32 subjects completed an exercise protocol known to affect mucosal immunity. ...E 3.4 days). The results suggest th …
This investigation examined the effects of Echinacea purpurea on mucosal immunity and the incidence and duration of upper respiratory …
Investigating the effect of echinacea extraction syrup on the outcomes of lower respiratory infections in patients with COVID-19: a randomized clinical trial study.
Kheirandish E, Mahdizadeh M, Mahdizadeh M, Rezaeitalab F, Yousefi M, Shojaee SSR. Kheirandish E, et al. Virol J. 2024 Dec 19;21(1):319. doi: 10.1186/s12985-024-02586-6. Virol J. 2024. PMID: 39702335 Free PMC article. Clinical Trial.
This study was conducted with the aim of determining the effect of Echinacea extract syrup on the outcomes of the lower respiratory tract in patients with COVID-19. ...More studies should be conducted to investigate the clinical effects of Echinacea extrac …
This study was conducted with the aim of determining the effect of Echinacea extract syrup on the outcomes of the lower respir …
Echinacea purpurea for prevention of experimental rhinovirus colds.
Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto AS. Sperber SJ, et al. Clin Infect Dis. 2004 May 15;38(10):1367-71. doi: 10.1086/386324. Epub 2004 Apr 26. Clin Infect Dis. 2004. PMID: 15156472 Free PMC article. Clinical Trial.
A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the ability of Echinacea purpurea to prevent infection with rhinovirus type 39 (RV-39). Forty-eight previously healthy adults received echinacea or placebo, 2.5 mL 3 times per da …
A randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the ability of Echinacea purpurea to prevent …
The effects of combination of Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: a randomized controlled trial.
Mesri M, Esmaeili Saber SS, Godazi M, Roustaei Shirdel A, Montazer R, Koohestani HR, Baghcheghi N, Karimy M, Azizi N. Mesri M, et al. J Complement Integr Med. 2021 Mar 31;18(4):775-781. doi: 10.1515/jcim-2020-0283. J Complement Integr Med. 2021. PMID: 33787192 Free article. Clinical Trial.
The effects of two herbal medicines namely Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients were examined. ...The intervention group received concurrent Zingiber officinale (Tablet Vomigone 500 …
The effects of two herbal medicines namely Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization …
Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.
Oláh A, Szabó-Papp J, Soeberdt M, Knie U, Dähnhardt-Pfeiffer S, Abels C, Bíró T. Oláh A, et al. J Dermatol Sci. 2017 Oct;88(1):67-77. doi: 10.1016/j.jdermsci.2017.05.015. Epub 2017 May 27. J Dermatol Sci. 2017. PMID: 28610718 Clinical Trial.
OBJECTIVE: To assess the putative efficacy of Echinacea purpurea-derived alkylamides (Ec. extract) activating cannabinoid (CB)-2 receptors in exerting anti-inflammatory effects and alleviating symptoms of AE. ...
OBJECTIVE: To assess the putative efficacy of Echinacea purpurea-derived alkylamides (Ec. extract) activating cannabinoid (CB)-2 rece …
Echinacea-Based Dietary Supplement Does Not Increase Maximal Aerobic Capacity in Endurance-Trained Men and Women.
Stevenson JL, Krishnan S, Inigo MM, Stamatikos AD, Gonzales JU, Cooper JA. Stevenson JL, et al. J Diet Suppl. 2016;13(3):324-38. doi: 10.3109/19390211.2015.1036189. Epub 2015 Aug 28. J Diet Suppl. 2016. PMID: 26317662 Clinical Trial.
PURPOSE: To determine if an echinacea-based dietary supplement (EBS) provided at two different doses (a regular dose (RD), 8,000 mg/day, vs. a double dose (DD), 16,000 mg/day) would increase erythropoietin (EPO) and other blood markers involved in improving aerobic capacit …
PURPOSE: To determine if an echinacea-based dietary supplement (EBS) provided at two different doses (a regular dose (RD), 8,000 mg/d …
75 results